Search

Your search keyword '"Godeau, Bertrand"' showing total 1,094 results

Search Constraints

Start Over You searched for: Author "Godeau, Bertrand" Remove constraint Author: "Godeau, Bertrand"
1,094 results on '"Godeau, Bertrand"'

Search Results

1. SARS-CoV-2 Omicron BA.1 breakthrough infection drives late remodeling of the memory B cell repertoire in vaccinated individuals

2. Prolonged response after TPO-RA discontinuation in primary ITP: results of a prospective multicenter study

3. Pregnancy outcomes in women with primary Sjögren's syndrome: an analysis of data from the multicentre, prospective, GR2 study

4. Immune thrombocytopenia and pregnancy: an exposed/nonexposed cohort study

5. Precipitating factors of catastrophic antiphospholipid syndrome: the role of anticoagulant treatment in a series of 112 patients

6. Characterisation of a high-risk profile for maternal thrombotic and severe haemorrhagic complications in pregnant women with antiphospholipid syndrome in France (GR2): a multicentre, prospective, observational study

8. Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen : observational comparative study using routine care data

9. COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study

11. Clinical presentation, course, and prognosis of patients with mixed connective tissue disease: A multicenter retrospective cohort.

12. Difficult‐to‐treat primary immune thrombocytopenia in adults: Prevalence and burden. Results from the CARMEN‐France registry.

13. Utilization of intravenous or subcutaneous immunoglobulins in secondary immune deficiency (ULTIMATE): A retrospective multicenter study

14. Clinical presentation, course, and prognosis of patients with mixed connective tissue disease: A multicenter retrospective cohort

16. Updated international consensus report on the investigation and management of primary immune thrombocytopenia

18. Analysis of risk factors for complications and adverse obstetrical outcomes in women with Takayasu arteritis: a French retrospective study and literature review

20. Haematological immune-related adverse events induced by anti-PD-1 or anti-PD-L1 immunotherapy: a descriptive observational study

21. Platelet count threshold for hemorrhage in patients with immune thrombocytopenia treated with antiplatelet agents

23. P1613: REAL-WORLD USE OF FOSTAMATINIB IN FRANCE. INTERIM RESULTS OF A NATIONAL REGISTRY.

24. Qualitative monitoring of SARS-CoV-2 mRNA vaccination in humans using droplet microfluidics

25. Combining thrombopoietin receptor agonists with immunosuppressive drugs in adult patients with multirefractory immune thrombocytopenia, an update on the French experience

26. Pregnancy outcomes in women with primary Sjögren's syndrome: an analysis of data from the multicentre, prospective, GR2 study

27. Efficacy and safety of two rituximab biosimilars for treating immune thrombocytopenia: a reference-product matched study

28. Adolescents and young adults with newly diagnosed primary immune thrombocytopenia

30. Dupilumab for relapsing or refractory sinonasal and/or asthma manifestations in eosinophilic granulomatosis with polyangiitis: a European retrospective study.

31. Is splenectomy a good strategy for refractory immune thrombocytopenia in adults?

32. Chronic refractory immune thrombocytopenia in adolescents and young adults.

34. Omicron BA.1 breakthrough infection drives long-term remodeling of the memory B cell repertoire in vaccinated individuals

35. Cutaneous Involvement in Catastrophic Antiphospholipid Syndrome in a Multicenter Cohort of 65 Patients

37. Characteristics, outcome, and response to therapy of multirefractory chronic immune thrombocytopenia

38. Omicron BA.1 breakthrough infection drives long-term remodeling of the memory B cell repertoire in vaccinated individuals

39. Update in Neurocritical Care: a summary of the 2018 Paris international conference of the French Society of Intensive Care

40. Determination of four homogeneous subgroups of patients with antiphospholipid syndrome: a cluster analysis based on 509 cases.

41. Characterisation of a high-risk profile for maternal thrombotic and severe haemorrhagic complications in pregnant women with antiphospholipid syndrome in France (GR2): a multicentre, prospective, observational study

42. Multirefractory Primary Immune Thrombocytopenia in Adults: Prevalence and Burden. Results from the Carmen-France Registry

45. Platelet Count Threshold Associated with Bleeding in Adult Patients with Immune Thrombocytopenia Treated with Antiplatelet Drugs. Results from the Carmen-France Registry

46. Human type I IFN deficiency does not impair B cell response to SARS-CoV-2 mRNA vaccination

47. Determination of four homogeneous subgroups of patients with antiphospholipid syndrome: a cluster analysis based on 509 cases

49. Safety and efficacy of rituximab in adult immune thrombocytopenia: results from a prospective registry including 248 patients

50. Ibrutinib as a treatment of hematologic autoimmune disorders in patients with indolent B‐cell lymphoma

Catalog

Books, media, physical & digital resources